Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „week“
Suchtreffer
Begriffe & Kennungen
Benlysta · 4.8 · In a 52-week open-label study in which 25 paediatric patients (10 to 17 years of age) with SLE received subcut
Eintrag öffnenBenlysta · 4.8 · In a 52-week open-label study in which 25 paediatric patients (10 to 17 years of age) with SLE received subcut
Eintrag öffnenBenlysta · 4.8 · In a 52-week open-label study in which 25 paediatric patients (10 to 17 years of age) with SLE received subcut
Eintrag öffnenBenlysta · 4.8 · In a 52-week placebo-controlled study in which 53 patients (6 to 17 years of age) with SLE received Benlysta (
Eintrag öffnenBenlysta · 4.8 · In a 52-week placebo-controlled study in which 53 patients (6 to 17 years of age) with SLE received Benlysta (
Eintrag öffnenBenlysta · 4.8 · In a 52-week placebo-controlled study in which 53 patients (6 to 17 years of age) with SLE received Benlysta (
Eintrag öffnenBenlysta · 4.8 · In a randomised, double-blind, 52-week, post-marketing safety SLE study (BEL115467) which assessed mortality a
Eintrag öffnenBenlysta · 4.8 · In a randomised, double-blind, 52-week, post-marketing safety SLE study (BEL115467) which assessed mortality a
Eintrag öffnenBenlysta · 4.8 · In a randomised, double-blind, 52-week, post-marketing safety SLE study (BEL115467) which assessed mortality a
Eintrag öffnenBeovu · 4.8 · DME After dosing with Beovu for 96 weeks, treatment-emergent anti-brolucizumab antibodies were detected in 16-
Eintrag öffnenBeovu · 4.8 · Wet AMD After dosing with Beovu for 88 weeks, treatment-emergent anti-brolucizumab antibodies were detected in
Eintrag öffnenBesremi · 4.5 · Administration of 180 micrograms of pegylated interferon alfa-2a once weekly for 4 weeks in healthy male subje
Eintrag öffnenBeyfortus · 4.8 · Table 1 presents the adverse reactions reported in 2 966 term and preterm infants (GA ≥29 weeks) who received
Eintrag öffnenBimzelx · 4.8 · Approximately 44% of patients with AS treated with bimekizumab up to 52 weeks at the recommended dosing regime
Eintrag öffnenBimzelx · 4.8 · Approximately 45% of plaque psoriasis patients treated with bimekizumab up to 56 weeks at the recommended dosi
Eintrag öffnenBimzelx · 4.8 · Approximately 57% of patients with nr-axSpA treated with bimekizumab up to 52 weeks at the recommended dosing
Eintrag öffnenBimzelx · 4.8 · Approximately 59% of HS patients treated with bimekizumab up to 48 weeks at the recommended dosing regimen (32
Eintrag öffnenBrintellix · 4.8 · Nausea Nausea was usually mild or moderate and occurred within the first two weeks of treatment. The reactions
Eintrag öffnenBrintellix · 4.8 · Nausea Nausea was usually mild or moderate and occurred within the first two weeks of treatment. The reactions
Eintrag öffnenCabometyx · 4.8 · In a dataset of cabozantinib 40 mg once daily in combination with nivolumab 240 mg every two weeks in RCC (n =
Eintrag öffnen